Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting ( ICCR )
Histopathology · 2023
DOI: 10.1111/his.15047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, 2023. Verfasst von Anja C Roden und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms, Neoplasms, Glandular and Epithelial, Neuroendocrine Tumors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Abstract (Originalsprache)
Aims
Thymic epithelial tumours (TET), including thymomas and thymic carcinomas and thymic neuroendocrine neoplasms, are malignant neoplasms that can be associated with morbidity and mortality. Recently, an updated version of the World Health Organization (WHO) Classification of Thoracic Tumours 5th Edition, 2021 has been released, which included various changes to the classification of these neoplasms. In addition, in 2017 the Union for International Cancer Control (UICC) / American Joint Committee on Cancer (AJCC) published the 8th Edition Staging Manual which, for the first time, includes a TNM staging that is applicable to thymomas, thymic carcinomas, and thymic neuroendocrine neoplasms. Methods and Results To standardize reporting of resected TET and thymic neuroendocrine neoplasms the accrediting bodies updated their reporting protocols. The International Collaboration on Cancer Reporting (ICCR), which represents a collaboration between various National Associations of Pathology, updated its 2017 histopathology reporting guide on TET and thymic neuroendocrine neoplasms accordingly. This report will highlight important changes in the reporting of TET and thymic neuroendocrine neoplasms based on the 2021 WHO, emphasize the 2017 TNM staging, and also comment on the rigour and various uncertainties for the pathologist when trying to follow that staging.
Conclusion
The ICCR dataset provides a comprehensive, standardized template for reporting of resected TET and thymic neuroendocrine neoplasms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
- International Collaboration on Cancer Reporting, Sydney, NSW, Australia.
- Maasstad Hospital, Rotterdam, The Netherlands.
- Academic Hospital Erasmus MC, Rotterdam, The Netherlands.
- Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai, China.
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India.
ORCID-Profile: Anja C Roden, Michael A den Bakker, Deepali Jain, Andre L Moreira, Philipp Stroebel, Wendy A Cooper
Zitieren
APA
Roden, A. C., Judge, M., den Bakker, M. A., Fang, W., Jain, D., Marx, A., Moreira, A. L., Rajan, A., Stroebel, P., Szolkowska, M., & Cooper, W. A. (2023). Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting ( ICCR ). Histopathology. https://doi.org/10.1111/his.15047
Vancouver
Roden AC, Judge M, den Bakker MA, Fang W, Jain D, Marx A, et al. Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting ( ICCR ). Histopathology. 2023. doi:10.1111/his.15047
BibTeX
@article{Roden2023,
author = {Roden, Anja C and Judge, Meagan and den Bakker, Michael A and Fang, Wentao and Jain, Deepali and Marx, Alexander and Moreira, Andre L and Rajan, Arun and Stroebel, Philipp and Szolkowska, Malgorzata and Cooper, Wendy A},
title = {Dataset for reporting of thymic epithelial tumours: recommendations from the International Collaboration on Cancer Reporting ( ICCR )},
journal = {Histopathology},
year = {2023},
doi = {10.1111/his.15047}
}
EUVIMED